This is a critical abstract of an economic evaluation that meets the criteria for inclusion on NHS EED. Each abstract contains a brief summary of the methods, the results and conclusions followed by a detailed critical assessment on the reliability of the study and the conclusions drawn.
Validity of estimate of measure of effectiveness
The analysis was based on a randomised controlled trial which was appropriate for this study, although practitioners were not blinded to allocation of patients, which the authors acknowledged could have introduced bias. The study sample selected appears to have been appropriate for the study population under examination and its size was determined by power calculations. Patient groups were shown to be comparable at analysis, and results were based on the intention to treat. The validity of the results was also enhanced by appropriate statistical analyses.
Validity of estimate of measure of benefit
The estimate of benefits used in the economic analysis, the incidence of post-operative vomiting, was taken directly from the effectiveness analysis. This was appropriate.
Validity of estimate of costs
The cost perspective adopted in the analysis was never clearly stated in the paper. The authors acknowledged that their cost analysis was very limited, as only the costs of drugs used in anaesthesia and administration tubing required were included in the analysis. The authors also acknowledged that, in addition to many direct costs being omitted, the economic analysis should also have included indirect costs such as lost productivity (for parents) and educational attainment (for children). They implicitly noted that the results of their analysis could have been affected by these factors, when acknowledging that the costs of drugs represented only a small fraction of total costs. Costs and quantities were reported separately. Resource use in the analysis was taken from the clinical study, but no statistical analysis of quantities to test against uncertainty was reported in the paper. The source of unit cost data for anaesthetic drugs used in the analysis does not appear to have been stated. The base price year used in the analysis does not appear to have been stated, which limits the generalisability of the results to other settings.
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